跳至主要内容
临床试验/NCT01698892
NCT01698892终止4 期

Comparison of Respiratory Tolerance to I.V. Versus Sublingual Sedation During Bronchoscopy.

Nantes University Hospital1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
85
试验地点
1
主要终点
Intensity of dyspnea

研究概览

简要总结

Bronchoscopy is a technique which currently allows the investigation of many respiratory diseases (infections, neoplasia, inflammation...) as well as endobronchial therapeutic procedures.

Good flexible bronchoscopy diagnostic practices suggest the use of anxiolytic premedication before endoscopy, but practices concerning the use of sedation further to the completion of the endoscopy are very heterogeneous.

We thus propose to compare, during a randomize, controlled trial, respiratory tolerance to I.V. versus sublingual sedation in two groups of patients indergoing bronchoscopy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women aged between 18 and 80, who will undergo bronchoscopy
  • FEV1≥ 50% of theorical value
  • Ambient air saturation at rest ≥ 94%
  • No allergy to midazolam, to hydroxyzine, Lidocaine (used for local anesthesia) or one of their compound
  • fasting for at least 6 hours
  • No indication against bronchoscopy, nor to premedication
  • Informed consent signed

排除标准

  • Pregnant or lactating, women
  • PAH patients
  • patients undergoing bronchoscopy with bronchoalveolar lavage and / or trans-bronchial biopsy
  • Patients with oral anticoagulants

研究组 & 干预措施

I.V. sedation

Experimental

Patients who will undergo bronchoscopy will be followed during one day. They will be randomized in the I.V. sedation

干预措施: I.V Sedation (Drug)

sublingual sedation

Active Comparator

Patients who will undergo bronchoscopy will be followed during one day. They will be randomized in the sublingual sedation group

干预措施: sublingual sedation (Drug)

结局指标

主要结局

Intensity of dyspnea

时间窗: 1 day

Intensity of dyspnea assessed by the patient 1h after bronchoscopy in both groups measured by VAS (visual analogue scale) score (in millimeters on a 0 to 100 scale).

次要结局

  • OAAS Score(1 day)
  • VAS Individual scores(1 day)
  • Bronchoscopy duration(1 day)
  • Blood pressure(1 day)
  • Desaturation frequency(1 day)
  • heart rate(1 day)
  • Comparison of midazolam total dose(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验